If given incorrectly, intramuscular injections may result in poor absorption of drug, reduced drug effectiveness, or irritation to surrounding tissues. In this study, IM injection techniques were observed and documented for needle length, injection site, needle insertion, and stretching or bunching of the skin during injection in a population of adult females. The patients’ weights and BMIs were recorded to determine the amount of subcutaneous fat at the injection site. In 22 patients of varied weights, 90% of injections were given within current Advisory Committee on Immunization Practice (ACIP) guidelines in normal and underweight patients, and 17% were given within ACIP guidelines in overweight and obese patients. The study concluded that the needle length used is often too short in overweight and obese individuals.
To offer an Needle Guide Asisstant with a 80mm Needle length in a Delivery System,
this Innovation will transform everyday life of injections.
Must be delivered to the correct tissue layer
According to WHO there are more than 2.1 billion overweight people globally. Millions of these are under medical treatment and too big to receive an intramuscular injection. As a result Doctors and Nurses have to do the injections at home or at a clinic. It is a huge problem as lots of medication are designed and approved to be stored in the muscle tissue in order to achieve full efficiency.
This injector is built from high quality materials
Design and Functionality guarantees the most
convenient and safe injection.
This device innovation from Union Medico opens up entirely new possibilities of medical care. For the first time it is possible for people with a high BMI to carry out a Self-Injection at home with an Needle Guide Asisstant. Good news for the users and Good news for public healthcare cost by Reduced hospital/doctor visits for injections.